AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...

(0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility

(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection

(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End

(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery

(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories

To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.

Image credit: Quartz

What is Science News Daily?

Welcome to Science News Daily, brought to you by Brief! Our AI selects the latest stories and top headlines and then delivers them to you each day in less than ten minutes (for more details, visit www.brief.news/how-it-works). Tune in to get your daily news on fascinating topics, including physics, biology, chemistry, astronomy, and more. Whether you're a science enthusiast, researcher, or simply curious about the wonders of the natural world, this podcast is your ultimate source for all things science. Tune in daily to stay up-to-date with the latest scientific breakthroughs.

Want to get these updates by email? Subscribe to Brief today https://www.brief.news/